DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
D-Tryptophan is an investigational drug.
There have been 13 clinical trials for D-Tryptophan. The most recent clinical trial was a Phase 1 trial, which was initiated on August 1st 2003.
The most common disease conditions in clinical trials are Breast Neoplasms, Adenocarcinoma, and Pancreatic Neoplasms. The leading clinical trial sponsors are National Cancer Institute (NCI), NewLink Genetics Corporation, and Southwest Oncology Group.
Recent Clinical Trials for D-Tryptophan
|Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer||National Cancer Institute (NCI)||Phase 3|
|Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer||Southwest Oncology Group||Phase 3|
|Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer||University of Colorado, Denver||Phase 2|